BCI-FES System for Quadriplegia
(ReHAB Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new system called the BCI and FES (Brain-Computer Interface and Functional Electrical Stimulation) that might help people with severe arm paralysis regain some movement. Researchers place tiny electrodes in the brain and arm to connect the brain's movement intentions to actual muscle activity. The study aims to determine if this system is safe and effective. Individuals with paralysis from a spinal cord injury or stroke for over a year, with stable symptoms, might be suitable candidates. As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research that could transform paralysis treatment.
Do I have to stop taking my current medications for the trial?
The trial does not specify if you must stop taking your current medications, but it excludes those who use certain medications like sedatives, anticoagulants, steroids, or immunosuppressants regularly. It's best to discuss your specific medications with the trial team.
What prior data suggests that this system is safe for people with quadriplegia?
Research has shown that using a brain-computer interface (BCI) with functional electrical stimulation (FES) can be safe for people with paralysis. Studies have found that this system can significantly improve movement in individuals with tetraplegia, which is paralysis of all four limbs. In one study, participants experienced better movement without any serious side effects.
The BCI-FES system works by placing electrodes in the brain and connecting them to the muscles, helping to turn brain signals into muscle movements. Previous trials have demonstrated that participants generally tolerate this combination well, with no major negative effects linked to the technology itself.
Overall, while researchers continue to study this treatment, early results suggest it is generally safe for people with severe paralysis. Participants in similar studies have shown improvements with minimal risks.12345Why are researchers excited about this trial?
Researchers are excited about the BCI-FES system for quadriplegia because it combines brain-computer interface (BCI) technology with functional electrical stimulation (FES) to offer a novel way to restore movement. Unlike traditional treatments that rely on physical therapy or assistive devices, this system directly interfaces with the brain to translate thoughts into actions, which can potentially lead to more natural and precise control of paralyzed limbs. This innovative approach could significantly enhance the quality of life for individuals with quadriplegia by providing them with more independence and control over their movements.
What evidence suggests that the BCI and FES system is effective for quadriplegia?
Studies have shown that brain-computer interfaces (BCI) combined with functional electrical stimulation (FES) can help people with paralysis regain movement. This system uses small electrodes in the brain to detect intended movements and then stimulates the muscles to execute these movements. Research indicates that BCI-FES can lead to significant and lasting improvements in movement recovery. Specifically, patients with spinal cord injuries have experienced better muscle function with this method. Initial findings suggest it may help people with quadriplegia move their arms and hands more effectively. Participants in this trial will receive the BCI and FES system, which involves surgical implantation of the device and testing for 13 months, with an optional 5-year extension study.13467
Who Is on the Research Team?
Jennifer Sweet, M.D.
Principal Investigator
University Hospitals Cleveland Medical Center
Are You a Good Fit for This Trial?
This trial is for adults aged 22-65 with stable tetraplegia from spinal cord injury or stroke, who live within a three-hour drive of the study site (or can relocate) and have a life expectancy over 13 months. Participants need intact brain motor areas, reliable communication ability, and a strong support system. They must not be pregnant, on certain medications, or have conditions that conflict with the study requirements.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Surgical Implantation and Initial Testing
Surgical implantation of the ReHAB system and initial testing of the device
Device Testing and Evaluation
Participants undergo testing and evaluation of the implanted device for safety, tolerability, and efficacy
Follow-up
Participants are monitored for safety and effectiveness after the initial 13-month testing period
Long-term Extension (optional)
Participants may opt into a long-term study to continue using the device for up to 5 years
What Are the Treatments Tested in This Trial?
Interventions
- BCI and FES
Find a Clinic Near You
Who Is Running the Clinical Trial?
Jennifer Sweet, MD
Lead Sponsor
Jonathan Miller, MD
Lead Sponsor